The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

By Guerard Pascal   Rakotoniaina Zo   Goirand Françoise   Rochette Luc   Dumas Monique   Lirussi Frederic   Bardou Marc  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 6, 2006-09 ,pp. : 401-414

Springer Publishing Company

Access to resources Recommend Favorite

eNOS haplotypes associated with gestational hypertension or preeclampsia

By Sandrim Valeria C   Palei Ana CT   Cavalli Ricardo C   Araúújo Francielle M   Ramos Ester S   Duarte Geraldo   Tanus-Santos Jose E  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1467-1473

Future Medicine

Access to resources Recommend Favorite

Reduction of eNOS in Vascular Smooth Muscle by Salt Independently of Hypertension

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 135-144

Bentham Science Publishers

Access to resources Recommend Favorite

eNOS phosphorylation and translocation are altered in male but not female mice by increased activation of the Gα_q protein

By Ruiz-Holst C.   Bölck B.   Ghanem A.   Tiemann K.   Brokat S.   Regitz-Zagrosek V.   Bloch W.   Schwinger Robert H.G.   Brixius K.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 2, 2010-02 ,pp. : 121-129

NRC Research Press

Access to resources Recommend Favorite

Pharmacological Prevention of eNOS Uncoupling

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3595-3606

Bentham Science Publishers

Access to resources Recommend Favorite